Latest News about IGXT
Recent news which mentions IGXT
Tickers
IGXT
From InvestorPlace
Tickers
IGXT
From InvestorPlace
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
January 15, 2024
From Benzinga
Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
May 15, 2023
From Benzinga
FDA Gives Nod To IntelGenx's Migraine Solution As Revenues Plunge 32%; Q1 Results Report
May 11, 2023
Tickers
IGXT
From Benzinga
Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
April 05, 2023
From Benzinga
From Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
January 31, 2023
From Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
January 30, 2023
From Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
January 27, 2023
From Benzinga
Psychedelic Stock Gainers And Losers From January 26, 2023
January 26, 2023
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023
January 24, 2023
From Benzinga
Psychedelic Stock Gainers And Losers From January 19, 2023
January 19, 2023
From Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
January 16, 2023
From Benzinga
Psychedelic Stock Gainers And Losers From January 13, 2023
January 13, 2023
From Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
January 12, 2023
From Benzinga
Cathie Wood Reacts To Atai's Drastic Stock Plunge After Doomed Clinical Study Results
January 12, 2023
From Benzinga
IntelGenx Reports Q3 2022 Financial Results, Management Anticipates Psychedelics Trials In 2023
November 10, 2022
Tickers
IGXT
From Benzinga
New Oral Film Tech Improving Cannabinoid Onset Seeks Patent Protection
November 03, 2022
From Benzinga
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From July 29, 2022
July 29, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga